Reuters logo
BRIEF-Juno Therapeutics and Trianni sign licensing agreement for use of Trianni Transgenic Mouse platform
2017年10月18日 / 下午1点05分 / 1 个月前

BRIEF-Juno Therapeutics and Trianni sign licensing agreement for use of Trianni Transgenic Mouse platform

Oct 18 (Reuters) - Juno Therapeutics Inc:

* Trianni and Juno Therapeutics sign licensing agreement for use of Trianni Transgenic Mouse platform

* Juno - to use Trianni Mouse with its single cell sequencing technology to identify fully-human binders for conversion to chimeric antigen receptors

* Juno Therapeutics Inc - ‍no financial details were disclosed​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below